We are live on ! Find out more
IMNN icon

Imunon
IMNN

37 hedge funds and large institutions have $11.5M invested in Imunon in 2021 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 12 increasing their positions, 6 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 6

7% more call options, than puts

Call options by funds: $344K | Put options by funds: $322K

5.38% less ownership

Funds ownership: 15.83% → 10.46% (-5.4%)

8% less funds holding

Funds holding: 40 → 37 (-3)

27% less first-time investments, than exits

New positions opened: 8 | Existing positions closed: 11

64% less capital inflows, than outflows

Capital inflows: $2.33M | Capital outflows: $6.47M

Holders
37
Holders Change
-3
Holders Change %
-7.5%
% of All Funds
0.64%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
12
Reduced
6
Closed
11
Calls
$344K
Puts
$322K
Net Calls
+$22K
Net Calls Change
+$95K

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$672K
2
Renaissance Technologies
Renaissance Technologies
New York
+$410K
3
State Street
State Street
Massachusetts
+$259K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$226K
5
Millennium Management
Millennium Management
New York
+$217K

Top Sellers

Rank Fund Capital Flow
1
ACM
Altium Capital Management
New York
-$4.82M
2
CVI Holdings
CVI Holdings
Delaware
-$466K
3
Morgan Stanley
Morgan Stanley
New York
-$399K
4
Marshall Wace
Marshall Wace
United Kingdom
-$179K
5
Squarepoint
Squarepoint
New York
-$143K

IMNN Hedge Fund Activity: Q2 2021 in Review

37 of the 5,769 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2021, worth a combined $11.5M — down 30% from $16.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of IMNN and 8 opened new positions — a net loss of 3 holders — while 6 trimmed existing stakes and 12 added.

The largest buyer was Vanguard Group, adding an estimated $672K. The largest seller was Altium Capital Management, exiting entirely with an estimated $4.82M sold.

  • 37 institutional investors held Imunon (IMNN) as of Q2 2021, down from 40 in Q1 2021.
  • Funds reported $11.5M of Imunon stock for Q2 2021, down 30% quarter-over-quarter.
  • 8 funds opened new Imunon positions in Q2 2021 and 11 closed out, a net change of -3 holders.
  • The largest Imunon buyer in Q2 2021 was Vanguard Group, an estimated $672K added.
  • The largest Imunon seller in Q2 2021 was Altium Capital Management, an estimated $4.82M sold.

Based on aggregated 13F filings for Q2 2021.